Chuck Royce's AORT Position Overview
Chuck Royce (via Royce & Associates Lp) currently holds 432,782 shares of Artivion, Inc. (AORT) worth $19.74 M, representing 0.20% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 51 quarters.
Based on 13F filings since 2013, Chuck Royce has maintained a long-term strategic position in AORT, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2022, adding 628,300 shares. Largest reduction occurred in Q4 2013, reducing 320,000 shares.
Analysis based on 13F filings available since 2013 Q2
Chuck Royce's Artivion (AORT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Artivion (AORT) Trades by Chuck Royce
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -96,965 | Reduce 18.30% | 432,782 | $45.61 |
| Q3 2025 | -186,933 | Reduce 26.08% | 529,747 | $42.34 |
| Q2 2025 | +29,260 | Add 4.26% | 716,680 | $31.10 |
| Q1 2025 | -143,580 | Reduce 17.28% | 687,420 | $24.58 |
| Q4 2024 | -40,170 | Reduce 4.61% | 831,000 | $28.59 |
| Q3 2024 | -133,210 | Reduce 13.26% | 871,170 | $26.62 |
| Q2 2024 | -115,241 | Reduce 10.29% | 1 M | $25.65 |
| Q1 2024 | +34,917 | Add 3.22% | 1.12 M | $21.16 |
| Q4 2023 | +96,700 | Add 9.79% | 1.08 M | $17.88 |
| Q3 2023 | +39,060 | Add 4.12% | 988,004 | $15.16 |
| Q2 2023 | -11,788 | Reduce 1.23% | 948,944 | $17.19 |
| Q1 2023 | +115,000 | Add 13.60% | 960,732 | $13.10 |
| Q4 2022 | -76,000 | Reduce 8.25% | 845,732 | $12.12 |
| Q3 2022 | +62,700 | Add 7.30% | 921,732 | $13.84 |
| Q2 2022 | +628,300 | Add 272.31% | 859,032 | $18.88 |
| Q1 2022 | +3,732 | Add 1.64% | 230,732 | $21.38 |
| Q4 2021 | -5,000 | Reduce 2.16% | 227,000 | $20.35 |
| Q2 2021 | -34,700 | Reduce 13.01% | 232,000 | $28.40 |
| Q1 2021 | -91,458 | Reduce 25.54% | 266,700 | $22.58 |
| Q3 2020 | +132,900 | Add 59.00% | 358,158 | $18.47 |
| Q2 2020 | +24,066 | Add 11.96% | 225,258 | $19.17 |
| Q1 2020 | -40,266 | Reduce 16.68% | 201,192 | $16.92 |
| Q4 2019 | -250,859 | Reduce 50.95% | 241,458 | $27.09 |
| Q3 2019 | +32,547 | Add 7.08% | 492,317 | $27.15 |
| Q2 2019 | +88,353 | Add 23.79% | 459,770 | $29.93 |
| Q1 2019 | +95,109 | Add 34.42% | 371,417 | $29.17 |
| Q4 2018 | -8,186 | Reduce 2.88% | 276,308 | $28.38 |
| Q3 2018 | -64,900 | Reduce 18.58% | 284,494 | $35.20 |
| Q2 2018 | -34,700 | Reduce 9.03% | 349,394 | $27.85 |
| Q1 2018 | -3,705 | Reduce 0.96% | 384,094 | $20.05 |
| Q4 2017 | -9,812 | Reduce 2.47% | 387,799 | $19.15 |
| Q3 2017 | -37,589 | Reduce 8.64% | 397,611 | $22.70 |
| Q2 2017 | +39,500 | Add 9.98% | 435,200 | $19.95 |
| Q1 2017 | +97,000 | Add 32.47% | 395,700 | $16.65 |
| Q4 2016 | -49,000 | Reduce 14.09% | 298,700 | $19.15 |
| Q3 2016 | -250,000 | Reduce 41.83% | 347,700 | $17.57 |
| Q2 2016 | -133,500 | Reduce 18.26% | 597,700 | $11.81 |
| Q1 2016 | +70,000 | Add 10.59% | 731,200 | $10.75 |
| Q4 2015 | -9,300 | Reduce 1.39% | 661,200 | $10.78 |
| Q3 2015 | +211,800 | Add 46.17% | 670,500 | $9.73 |
| Q2 2015 | +153,700 | Add 50.39% | 458,700 | $11.28 |
| Q1 2015 | -168,700 | Reduce 35.61% | 305,000 | $10.37 |
| Q4 2014 | -6,200 | Reduce 1.29% | 473,700 | $11.33 |
| Q3 2014 | -110,600 | Reduce 18.73% | 479,900 | $9.87 |
| Q2 2014 | -32,700 | Reduce 5.25% | 590,500 | $8.95 |
| Q1 2014 | -2,800 | Reduce 0.45% | 623,200 | $9.96 |
| Q4 2013 | -320,000 | Reduce 33.83% | 626,000 | $11.09 |
| Q3 2013 | -100,900 | Reduce 9.64% | 946,000 | $7.00 |
| Q2 2013 | +1.05 M | Add 0.00% | 1.05 M | $6.26 |
Chuck Royce's Artivion Investment FAQs
Chuck Royce first purchased Artivion, Inc. (AORT) in Q2 2013, acquiring 1,046,900 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chuck Royce has held Artivion, Inc. (AORT) for 51 quarters since Q2 2013.
Chuck Royce's largest addition to Artivion, Inc. (AORT) was in Q2 2013, adding 1,046,900 shares worth $6.55 M.
According to the latest 13F filing for Q4 2025, Chuck Royce's firm, Royce & Associates Lp, owns 432,782 shares of Artivion, Inc. (AORT), valued at approximately $19.74 M.
As of the Q4 2025 filing, Artivion, Inc. (AORT) represents approximately 0.20% of Chuck Royce's publicly disclosed stock portfolio, making it one of their key holdings.
Chuck Royce's peak holding in Artivion, Inc. (AORT) was 1,119,621 shares, as reported at the end of Q1 2024.